201 related articles for article (PubMed ID: 32518961)
1. Monocrotaline-induced liver toxicity in rat predicted by a combined in vitro physiologically based kinetic modeling approach.
Suparmi S; Wesseling S; Rietjens IMCM
Arch Toxicol; 2020 Sep; 94(9):3281-3295. PubMed ID: 32518961
[TBL] [Abstract][Full Text] [Related]
2. Use of an in vitro-in silico testing strategy to predict inter-species and inter-ethnic human differences in liver toxicity of the pyrrolizidine alkaloids lasiocarpine and riddelliine.
Ning J; Chen L; Strikwold M; Louisse J; Wesseling S; Rietjens IMCM
Arch Toxicol; 2019 Mar; 93(3):801-818. PubMed ID: 30661089
[TBL] [Abstract][Full Text] [Related]
3. Use of physiologically based kinetic modelling-facilitated reverse dosimetry to convert in vitro cytotoxicity data to predicted in vivo liver toxicity of lasiocarpine and riddelliine in rat.
Chen L; Ning J; Louisse J; Wesseling S; Rietjens IMCM
Food Chem Toxicol; 2018 Jun; 116(Pt B):216-226. PubMed ID: 29634986
[TBL] [Abstract][Full Text] [Related]
4. Prediction of in vivo genotoxicity of lasiocarpine and riddelliine in rat liver using a combined in vitro-physiologically based kinetic modelling-facilitated reverse dosimetry approach.
Chen L; Peijnenburg A; de Haan L; Rietjens IMCM
Arch Toxicol; 2019 Aug; 93(8):2385-2395. PubMed ID: 31289892
[TBL] [Abstract][Full Text] [Related]
5. Role of toxicokinetics and alternative testing strategies in pyrrolizidine alkaloid toxicity and risk assessment; state-of-the-art and future perspectives.
Ning J; Chen L; Rietjens IMCM
Food Chem Toxicol; 2019 Sep; 131():110572. PubMed ID: 31185270
[TBL] [Abstract][Full Text] [Related]
6. Physiologically based kinetic modelling predicts the in vivo relative potency of riddelliine N-oxide compared to riddelliine in rat to be dose dependent.
Widjaja F; Wesseling S; Rietjens IMCM
Arch Toxicol; 2022 Jan; 96(1):135-151. PubMed ID: 34669010
[TBL] [Abstract][Full Text] [Related]
7. Riddelliine N-oxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelliine.
Chou MW; Wang YP; Yan J; Yang YC; Beger RD; Williams LD; Doerge DR; Fu PP
Toxicol Lett; 2003 Dec; 145(3):239-47. PubMed ID: 14580895
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary toxicity is a common phenomenon of toxic pyrrolizidine alkaloids.
Song Z; He Y; Ma J; Fu PP; Lin G
J Environ Sci Health C Toxicol Carcinog; 2020; 38(2):124-140. PubMed ID: 32500835
[TBL] [Abstract][Full Text] [Related]
9. Prediction of dose-dependent in vivo acetylcholinesterase inhibition by profenofos in rats and humans using physiologically based kinetic (PBK) modeling-facilitated reverse dosimetry.
Omwenga I; Zhao S; Kanja L; Mol H; Rietjens IMCM; Louisse J
Arch Toxicol; 2021 Apr; 95(4):1287-1301. PubMed ID: 33651127
[TBL] [Abstract][Full Text] [Related]
10. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine.
Xia Q; Yan J; Chou MW; Fu PP
Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999
[TBL] [Abstract][Full Text] [Related]
11. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
Wang YP; Yan J; Fu PP; Chou MW
Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
[TBL] [Abstract][Full Text] [Related]
12. The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver.
Yan CC; Cooper RA; Huxtable RJ
Toxicol Appl Pharmacol; 1995 Aug; 133(2):277-84. PubMed ID: 7645024
[TBL] [Abstract][Full Text] [Related]
13. Pyrrolizidine alkaloids cause cell cycle and DNA damage repair defects as analyzed by transcriptomics in cytochrome P450 3A4-overexpressing HepG2 clone 9 cells.
Abdelfatah S; Naß J; Knorz C; Klauck SM; Küpper JH; Efferth T
Cell Biol Toxicol; 2022 Apr; 38(2):325-345. PubMed ID: 33884520
[TBL] [Abstract][Full Text] [Related]
14. Integrating physiologically based kinetic (PBK) and Monte Carlo modelling to predict inter-individual and inter-ethnic variation in bioactivation and liver toxicity of lasiocarpine.
Ning J; Rietjens IMCM; Strikwold M
Arch Toxicol; 2019 Oct; 93(10):2943-2960. PubMed ID: 31511935
[TBL] [Abstract][Full Text] [Related]
15. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, lasiocarpine.
Xia Q; Chou MW; Edgar JA; Doerge DR; Fu PP
Cancer Lett; 2006 Jan; 231(1):138-45. PubMed ID: 16356839
[TBL] [Abstract][Full Text] [Related]
16. Comparative Study of Hepatotoxicity of Pyrrolizidine Alkaloids Retrorsine and Monocrotaline.
Yang X; Li W; Sun Y; Guo X; Huang W; Peng Y; Zheng J
Chem Res Toxicol; 2017 Feb; 30(2):532-539. PubMed ID: 28095673
[TBL] [Abstract][Full Text] [Related]
17. Physiologically based kinetic modelling based prediction of in vivo rat and human acetylcholinesterase (AChE) inhibition upon exposure to diazinon.
Zhao S; Wesseling S; Spenkelink B; Rietjens IMCM
Arch Toxicol; 2021 May; 95(5):1573-1593. PubMed ID: 33715020
[TBL] [Abstract][Full Text] [Related]
18. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo.
Wang YP; Yan J; Beger RD; Fu PP; Chou MW
Cancer Lett; 2005 Aug; 226(1):27-35. PubMed ID: 16004930
[TBL] [Abstract][Full Text] [Related]
19. OCT1-dependent uptake of structurally diverse pyrrolizidine alkaloids in human liver cells is crucial for their genotoxic and cytotoxic effects.
Haas M; Ackermann G; Küpper JH; Glatt H; Schrenk D; Fahrer J
Arch Toxicol; 2023 Dec; 97(12):3259-3271. PubMed ID: 37676300
[TBL] [Abstract][Full Text] [Related]
20. Development of a Combined In Vitro Physiologically Based Kinetic (PBK) and Monte Carlo Modelling Approach to Predict Interindividual Human Variation in Phenol-Induced Developmental Toxicity.
Strikwold M; Spenkelink B; Woutersen RA; Rietjens IMCM; Punt A
Toxicol Sci; 2017 Jun; 157(2):365-376. PubMed ID: 28498972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
